BTEE.L vs. XGES.L
BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) and XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - BTEE.L tracks the NASDAQ Biotechnology TR USD while XGES.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 3 years, BTEE.L returned 13.12%/yr vs 4.13%/yr for XGES.L. Their correlation of 0.81 suggests significant overlap in exposure. Both charge a 0.35% expense ratio.
Performance
BTEE.L vs. XGES.L - Performance Comparison
Loading charts...
Different Trading Currencies
BTEE.L is traded in USD, while XGES.L is traded in GBP. To make them comparable, the XGES.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BTEE.L achieves a 4.58% return, which is significantly higher than XGES.L's -1.06% return.
BTEE.L
- 1D
- 3.30%
- 1M
- 1.17%
- YTD
- 4.58%
- 6M
- 3.18%
- 1Y
- 41.45%
- 3Y*
- 13.12%
- 5Y*
- 4.70%
- 10Y*
- —
XGES.L
- 1D
- 4.27%
- 1M
- 5.84%
- YTD
- -1.06%
- 6M
- -3.71%
- 1Y
- 24.80%
- 3Y*
- 4.13%
- 5Y*
- —
- 10Y*
- —
BTEE.L vs. XGES.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.58% | 32.82% | -1.69% | 5.84% | 4.40% |
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.06% | 19.61% | -3.03% | -3.06% | -7.53% |
Correlation
The correlation between BTEE.L and XGES.L is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.84 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022 | 0.81 |
The correlation between BTEE.L and XGES.L has been stable across timeframes, ranging from 0.81 to 0.84 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEE.L vs. XGES.L — Risk / Return Rank
BTEE.L
XGES.L
BTEE.L vs. XGES.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BTEE.L | XGES.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.79 | ||
| Sortino ratioReturn per unit of downside risk | +1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.23 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 5.41 | 1.60 | +3.81 |
| Martin ratioReturn relative to average drawdown | 16.70 | 3.83 | +12.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BTEE.L | XGES.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.10 | 1.32 | +0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.04 | +0.27 |
Drawdowns
BTEE.L vs. XGES.L - Drawdown Comparison
The maximum BTEE.L drawdown since its inception was -38.29%, which is greater than XGES.L's maximum drawdown of -32.16%. Use the drawdown chart below to compare losses from any high point for BTEE.L and XGES.L.
Loading charts...
Drawdown Indicators
| BTEE.L | XGES.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.29% | -32.16% | -6.13% |
Max Drawdown (1Y)Largest decline over 1 year | -7.63% | -15.47% | +7.84% |
Max Drawdown (3Y)Largest decline over 3 years | -26.82% | -25.76% | -1.06% |
Max Drawdown (5Y)Largest decline over 5 years | -38.29% | — | — |
Current DrawdownCurrent decline from peak | -2.58% | -7.39% | +4.81% |
Average DrawdownAverage peak-to-trough decline | -13.56% | -14.32% | +0.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.47% | 6.46% | -3.99% |
Volatility
BTEE.L vs. XGES.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) have volatilities of 6.84% and 6.66%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEE.L | XGES.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 6.66% | +0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 15.33% | 14.54% | +0.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.63% | 18.82% | +0.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.14% | 19.93% | +1.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.50% | 19.93% | +2.57% |
BTEE.L vs. XGES.L - Expense Ratio Comparison
Both BTEE.L and XGES.L have an expense ratio of 0.35%.
Dividends
BTEE.L vs. XGES.L - Dividend Comparison
BTEE.L's dividend yield for the trailing twelve months is around 0.36%, while XGES.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BTEE.L and XGES.L have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
BTEE.L and XGES.L have the same expense ratio: 0.35% per year.
BTEE.L tracks NASDAQ Biotechnology TR USD, while XGES.L tracks MSCI World/Health Care NR USD. They also come from different issuers: iShares and DWS.
Find the right allocation for BTEE.L and XGES.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer